Insider · CIK 0001509415

Leamon Christopher P

Reports to the SEC for 2 companies · WEST LAFAYETTE, IN

sec.gov

Transactions

Companies

Filings

CIK

0001509415

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-06-04	Fusion Pharmaceuticals Inc.D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−12K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−218K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−250K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−106K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Restricted Stock UnitsD Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−63.7K sh	—	—	0
2024-01-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+106K sh	—	—	106,100
2024-01-04	Fusion Pharmaceuticals Inc.Restricted Stock UnitsA Award	Chief Scientific Officer	AAward	+63.7K sh	—	—	63,700
2023-08-31	Fusion Pharmaceuticals Inc.A Award	Chief Scientific Officer	AAward	+12K sh	—	—	11,957
2023-01-05	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+250K sh	—	—	250,000
2021-11-01	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+218K sh	—	—	218,000
2018-12-21	ENDOCYTE INCD Disposition to Issuer	Vice President of Research	DDisposition to Issuer	−164K sh	$24.00	−$3.94M	0
2018-12-21	ENDOCYTE INCD Disposition to Issuer	Vice President of Research	DDisposition to Issuer	−4,375 sh	$24.00	−$105K	0
2018-12-21	ENDOCYTE INCD Disposition to Issuer	Vice President of Research	DDisposition to Issuer	−13.1K sh	$24.00	−$315K	0
2018-12-21	ENDOCYTE INCD Disposition to Issuer	Vice President of Research	DDisposition to Issuer	−20K sh	$24.00	−$480K	0
2018-12-21	ENDOCYTE INCD Disposition to Issuer	Vice President of Research	DDisposition to Issuer	−22.5K sh	$24.00	−$540K	0
2018-12-21	ENDOCYTE INCStock Option (right to buy)D Disposition to Issuer	Vice President of Research	DDisposition to Issuer	−27.5K sh	$14.95	−$411K	0
2018-12-21	ENDOCYTE INCStock Option (right to buy)D Disposition to Issuer	Vice President of Research	DDisposition to Issuer	−60K sh	$20.45	−$1.23M	0
2018-12-21	ENDOCYTE INCStock Option (right to buy)D Disposition to Issuer	Vice President of Research	DDisposition to Issuer	−70K sh	$14.14	−$990K	0
2018-12-21	ENDOCYTE INCStock Option (right to buy)D Disposition to Issuer	Vice President of Research	DDisposition to Issuer	−45K sh	$12.89	−$580K	0
2018-12-21	ENDOCYTE INCStock Option (right to buy)D Disposition to Issuer	Vice President of Research	DDisposition to Issuer	−52.5K sh	$18.90	−$992K	0
2018-12-21	ENDOCYTE INCStock Option (right to buy)D Disposition to Issuer	Vice President of Research	DDisposition to Issuer	−52.5K sh	$20.82	−$1.09M	0
2018-12-21	ENDOCYTE INCStock Option (right to buy)D Disposition to Issuer	Vice President of Research	DDisposition to Issuer	−35K sh	$21.84	−$764K	0
2018-12-21	ENDOCYTE INCStock Option (right to buy)D Disposition to Issuer	Vice President of Research	DDisposition to Issuer	−45K sh	$20.99	−$945K	0
2018-12-17	ENDOCYTE INCM Exercise/Conversion	Vice President of Research	MExercise/Conversion	+20K sh	$2.54	+$50.8K	142,482
2018-12-17	ENDOCYTE INCM Exercise/Conversion	Vice President of Research	MExercise/Conversion	+26.2K sh	$3.82	+$100K	168,659
2018-12-17	ENDOCYTE INCM Exercise/Conversion	Vice President of Research	MExercise/Conversion	+13.1K sh	$7.49	+$98K	181,748
2018-12-17	ENDOCYTE INCM Exercise/Conversion	Vice President of Research	MExercise/Conversion	+22.5K sh	$9.05	+$204K	204,248
2018-12-17	ENDOCYTE INCM Exercise/Conversion	Vice President of Research	MExercise/Conversion	+20K sh	$3.55	+$71K	224,252
2018-12-17	ENDOCYTE INCM Exercise/Conversion	Vice President of Research	MExercise/Conversion	+2 sh	$5.10	+$10.2	224,254
2018-12-17	ENDOCYTE INCM Exercise/Conversion	Vice President of Research	MExercise/Conversion	+2 sh	$3.18	+$6.36	224,256
2018-12-17	ENDOCYTE INCStock Option (right to buy)M Exercise/Conversion	Vice President of Research	MExercise/Conversion	−20K sh	—	—	0
2018-12-17	ENDOCYTE INCStock Option (right to buy)M Exercise/Conversion	Vice President of Research	MExercise/Conversion	−26.2K sh	—	—	0
2018-12-17	ENDOCYTE INCStock option (right to buy)M Exercise/Conversion	Vice President of Research	MExercise/Conversion	−13.1K sh	—	—	0
2018-12-17	ENDOCYTE INCStock Option (right to buy)M Exercise/Conversion	Vice President of Research	MExercise/Conversion	−22.5K sh	—	—	27,500
2018-12-17	ENDOCYTE INCStock option (right to buy)M Exercise/Conversion	Vice President of Research	MExercise/Conversion	−20K sh	—	—	59,996
2018-12-17	ENDOCYTE INCStock option (right to buy)M Exercise/Conversion	Vice President of Research	MExercise/Conversion	−2 sh	—	—	52,498
2018-12-17	ENDOCYTE INCStock option (right to buy)M Exercise/Conversion	Vice President of Research	MExercise/Conversion	−2 sh	—	—	52,498
2018-10-05	ENDOCYTE INCS Sale	Vice President of Research	SSale	−9,028 sh	$15.56	−$140K	122,219
2018-10-05	ENDOCYTE INCS Sale	Vice President of Research	SSale	−9,028 sh	$15.56	−$140K	121,353
2018-08-29	ENDOCYTE INCM Exercise/Conversion	Vice President of Research	MExercise/Conversion	+4,696 sh	$2.54	+$11.9K	135,077
2018-08-29	ENDOCYTE INCS Sale	Vice President of Research	SSale	−4,696 sh	$20.00	−$93.9K	130,381
2018-08-29	ENDOCYTE INCStock Option (right to buy)M Exercise/Conversion	Vice President of Research	MExercise/Conversion	−4,696 sh	—	—	20,000
2018-08-28	ENDOCYTE INCM Exercise/Conversion	Vice President of Research	MExercise/Conversion	+12.7K sh	$2.54	+$32.2K	143,051
2018-08-28	ENDOCYTE INCS Sale	Vice President of Research	SSale	−12.7K sh	$20.00	−$253K	130,381
2018-08-28	ENDOCYTE INCStock Option (right to buy)M Exercise/Conversion	Vice President of Research	MExercise/Conversion	−12.7K sh	—	—	24,696
2018-06-12	ENDOCYTE INCS Sale	Vice President of Research	SSale	−13.1K sh	$15.06	−$197K	130,381
2018-03-09	ENDOCYTE INCS Sale	Vice President of Research	SSale	−5,036 sh	$9.07	−$45.7K	143,470
2018-02-08	ENDOCYTE INCA Award	Vice President of Research	AAward	+22.5K sh	—	—	148,506
2018-02-08	ENDOCYTE INCStock Option (right to buy)A Award	Vice President of Research	AAward	+45K sh	—	—	45,000
2018-02-06	ENDOCYTE INCF Tax Payment	Vice President of Research	FTax Payment	−638 sh	$3.00	−$1,914	126,006

Recent filings

Accepted (ET)
Jun 44
Leamon Christopher P0000950170-24-068879
SEC(opens sec.gov)
Jan 54
Leamon Christopher P0000950170-24-002301
SEC(opens sec.gov)
Jan 94
Leamon Christopher P0001209191-23-002497
SEC(opens sec.gov)
Nov 24
Leamon Christopher P0001209191-21-062419
SEC(opens sec.gov)
Dec 214
Leamon Christopher P0001104659-18-074357
SEC(opens sec.gov)

Companies

Address

3000 KENT AVE, SUITE A1-100

WEST LAFAYETTE, IN, 47906